Approvals/TGA/Hospira Irinotecan (Irinotecan Hydrochloride) 20 mg/mL Concentrate for Solution for Infusion 500 mg/25 mL vial

Approved

STANDARD

Hospira Irinotecan (Irinotecan Hydrochloride) 20 mg/mL Concentrate for Solution for Infusion 500 mg/25 mL vial

Hospira Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: befe88dc4878cec8
Product Name: Hospira Irinotecan (Irinotecan Hydrochloride) 20 mg/mL Concentrate for Solution for Infusion 500 mg/25 mL vial
Artg Id: 142148
Artg Name: Hospira Irinotecan (Irinotecan Hydrochloride) 20 mg/mL Concentrate for Solution for Infusion 500 mg/25 mL vial
Sponsor: Hospira Australia Pty Ltd
Company Detail Path: /organization/hospira-australia-pty-ltd
Artg Date: 2007-07-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

befe88dc4878cec8

Type

Standard